Conversely, EpCAM over-expression has been associated with both improved prognoses and favorable response to platinum based chemotherapy [23] further suggesting that epithelial differentiation leads to improved prognosis in ovarian cancer. This evidence concerns the gene EPCAM and ovarian cancer.